4//SEC Filing
MERRIMACK PHARMACEUTICALS INC 4
Accession 0001179110-15-004510
CIK 0001274792operating
Filed
Mar 8, 8:00 PM ET
Accepted
Mar 9, 4:16 PM ET
Size
8.1 KB
Accession
0001179110-15-004510
Insider Transaction Report
Form 4
Mulroy Robert J.
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2015-03-05$1.71/sh+22,385$38,278→ 1,361,701 total - Exercise/Conversion
Stock Option (right to buy)
2015-03-05−22,385→ 284,368 totalExercise: $1.71Exp: 2015-08-03→ Common Stock (22,385 underlying) - Sale
Common Stock
2015-03-05$12.50/sh−22,385$279,813→ 1,339,316 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]This option is fully vested.
Documents
Issuer
MERRIMACK PHARMACEUTICALS INC
CIK 0001274792
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001274792
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 8:00 PM ET
- Accepted
- Mar 9, 4:16 PM ET
- Size
- 8.1 KB